-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

112.P1.16 112. Thalassemia and Globin Gene Regulation: Poster I

Symposia: Thalassemia and Globin Gene Regulation Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Duran Canatan1,2,3*, Serpil Delibaş1*, Emel Altunsoy3*, Yunus Budak3*, Elif Gözde Gökkaya2*, Sultan Aydın4*, Defne Ay Tuncel5*, Priyaleela Thota6*, Akshat Jain, MD, MPH7 and Umut Gurkan, PhD8

1Hemoglobinopathy Diagnosis Thalassemia Center of Mediterranean Blood Diseases Foundation, Antalya, Turkey
2Antalya Bilim University, Antalya, Turkey
3Antalya Genetic Diseases Assessment Center, Antalya, Turkey
4Thalassemia Center, Health Sciences University, Antalya Education and Research Hospital, Antalya, Turkey
5Pediatric Hematology Oncology Clinic, Health Sciences University, Adana City Training and Research Hospital, Adana, Turkey
6Hemex Health, USA, Portland, OR
7Clinical Medicine and Pediatrics, Division of Hematology,Oncology and Cell Therapy, Loma Linda University School of Medicine, Redlands, CA
8Case Western Reserve University, Cleveland, OH

Sylvia Titi Singer, MD1, Yu Hou, PhD2*, Rajesh Sharma, PhD, FACMG3*, Elliott P. Vichinsky, MD4, Adriane Meyer, CGMBS5*, Jennifer Martinez, CLS5*, Cindy Wu, PhD6*, Tracey Bishop6* and Shabnam Tavassoli, PhD, CLS5*

1hematology/Oncology, UCSF Benioff Children's Hospital Oakland, Oakland, CA
2California Department of Public Helath, Genetic Disease Laboratory, Genetic Disease Screening Program, Richmond, CA
3Genetic Disease Screening Program, California Department of Public Health, Richmond, CA
4Department of Pediatrics, Division of Hematology, University of California San Francisco Benioff Children's Hospital, Oakland, CA
5Hemoglobin Reference Laboratory/UCSF Benioff Children's Hospital Oakland, Oakland, CA
6California Department of Public Health, Genetic Disease Screening Program, Richmond, CA

Xiao Liang1*, Gaohui Yang1*, Lingling Shi1*, Lianjin Liu1*, Zhenbin Wei1*, Yumei Huang1*, Jing Bai2*, Yi Liang2*, Lingyuan Pan1*, Zhaoping Gan1*, Yu Lin1*, Yibin Yao1*, Ying Tang1*, Huicheng Huang1*, Xuemei Zhou1*, Qifa Liu, MD3, Yongrong Lai, MD1,4,5* and Rongrong Liu1,4,5*

1Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
2Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
3Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
4NHC Key Laboratory of Thalassemia Medicine, Nanning, China
5Guangxi Key Laboratory of Thalassemia Research, Nanning, China

Kinza Khan1*, Farah O'Boyle2*, Kirstin Lund, MRCP, BSc3*, Toni Petterson4*, Sandrine Bremathas, RN5*, Kelly Hennessy6*, Adam Gassas, MD7*, Leena Karnik, FRCPath, MRCP8* and Josu de la Fuente, PhD FRCP9,10,11,12

1Imperial College London, Gillingham, ENG, United Kingdom
2St. Marys Hospital, London, United Kingdom
3St Marys Hospital, Imperial College London, London, GBR
4St Marys Hospital, Imperial College NHS Foundation Trust London, London, GBR
5IMPERIAL COLLEGE HEALTHCARE NHS TRUST, London, United Kingdom
6St Marys Hospital, Imperial College London, London, United Kingdom
7St Marys Hospital, Imperial College NHS Foundation Trust, London, United Kingdom
8St Marys Hospital, Imperial College NHS Foundation Trust, London, GBR
9Department of Paediatrics, St Mary’s Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
10Division of Immunology and Inflammation, Imperial College London, London, United Kingdom
11Imperial College Healthcare Trust, St Mary's Hospital, London, United Kingdom
12Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom

Kasey Fu1*, Katherine Lawson-Michod2*, Michael Goodman2*, Cathy Lally2* and Jelili Ojodu, MPH3*

1Vertex Pharmaceuticals Incorporated, Boston, MA
2Epidemiologic Research & Methods, LLC, Atlanta, GA
3Association of Public Health Laboratories, Silver Spring, MD

Olubunmi Ogunsanya, MD1*, Amrit Kirpalani, MD1*, Jennifer Zavitz2*, Ashley Geerlinks, MD1 and Soumitra Tole, MD, MSc1*

1Department of Pediatrics, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada
2Children's Hospital, London Health Sciences Center, London, ON, CAN

*signifies non-member of ASH